TRIS

Welcome to the Brand page for “TRIS”, which is offered here for Pharmaceutical preparations, beta-hydroxy beta-methylglutaryl-coa (hmg-coa) reductase inhibitors used to lower ldl cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (adhd); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (adhd); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (adhd); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain;providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations;.

Its status is currently believed to be active. Its class is unavailable. “TRIS” is believed to be currently owned by “TRIS PHARMA, INC”.